Pulmonx Corp logo

Pulmonx Corp

NAS:LUNG (USA)   Ordinary Shares
$ 11.03 -0.01 (-0.09%) 08:08 PM EST
At Loss
P/B:
3.36
Market Cap:
$ 422.54M
Enterprise V:
$ 348.66M
Volume:
229.77K
Avg Vol (2M):
236.19K
Also Trade In:
Volume:
229.77K
At Loss
Avg Vol (2M):
236.19K

Business Description

Pulmonx Corp logo
Pulmonx Corp
NAICS : 334510 SIC : 3842
ISIN : US7458481014

Share Class Description:

LUNG: Ordinary Shares
Description
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets.
Name Current Vs Industry Vs History
Cash-To-Debt 2.76
Equity-to-Asset 0.68
Debt-to-Equity 0.34
Debt-to-EBITDA -0.75
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.24
Distress
Grey
Safe
Beneish M-Score -1.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 72.99
9-Day RSI 69.87
14-Day RSI 65.21
6-1 Month Momentum % -28.65
12-1 Month Momentum % 53.93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.19
Quick Ratio 6.41
Cash Ratio 5.69
Days Inventory 327.23
Days Sales Outstanding 48.54
Days Payable 54.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.9
Shareholder Yield % -3.11

Financials (Next Earnings Date:2024-02-22 Est.)

LUNG's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LUNG

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Pulmonx Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 64.822
EPS (TTM) ($) -1.62
Beta 0.49
Volatility % 83.35
14-Day RSI 65.21
14-Day ATR ($) 0.573462
20-Day SMA ($) 10.237
12-1 Month Momentum % 53.93
52-Week Range ($) 5.3 - 14.275
Shares Outstanding (Mil) 38.31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pulmonx Corp Filings

Filing Date Document Date Form
No Filing Data

Pulmonx Corp Stock Events

Event Date Price($)
No Event Data

Pulmonx Corp Frequently Asked Questions

What is Pulmonx Corp(LUNG)'s stock price today?
The current price of LUNG is $11.03. The 52 week high of LUNG is $14.28 and 52 week low is $5.30.
When is next earnings date of Pulmonx Corp(LUNG)?
The next earnings date of Pulmonx Corp(LUNG) is 2024-02-22 Est..
Does Pulmonx Corp(LUNG) pay dividends? If so, how much?
Pulmonx Corp(LUNG) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1